A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
The University Hospital Olomouc is one of the largest in-patient facilities in the Czech Republic. It is part of a network of nine teaching hospitals directly managed by the Ministry of Health of the Czech Republic. It is the largest healthcare facility in the Olomouc Region and the sixth largest hospital in the country.
Olomouc, Czechia Clinical Trial Location
Onkologická klinika Fakultní nemocnice Olomouc
I.P. Pavlova 185/6, Nová Ulice,
779 00 Olomouc, Czechia